{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:22:33Z","timestamp":1774362153150,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T00:00:00Z","timestamp":1355011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00210-012-0814-3","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T18:23:13Z","timestamp":1360952593000},"page":"71-78","source":"Crossref","is-referenced-by-count":33,"title":["Effect of mirabegron, a novel \u03b23-adrenoceptor agonist, on bladder function during storage phase in rats"],"prefix":"10.1007","volume":"386","author":[{"given":"Toshiki","family":"Hatanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,9]]},"reference":[{"key":"814_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"814_CR2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.eururo.2012.08.056","volume":"62","author":"N Aizawa","year":"2012","unstructured":"Aizawa N, Homma Y, Igawa Y (2012) Effects of mirabegron, a novel \u03b23-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. Eur Urol: 62(6):1165\u201373. doi: 10.1016\/j.eururo.2012.08.056","journal-title":"Eur Urol:"},{"key":"814_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/nau.20826","volume":"29","author":"N Aizawa","year":"2010","unstructured":"Aizawa N, Igawa Y, Nishizawa O, Wyndaele JJ (2010) Effects of CI316,243, a \u03b23-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 29:771\u2013776","journal-title":"Neurourol Urodyn"},{"key":"814_CR4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","volume":"56","author":"K-E Andersson","year":"2004","unstructured":"Andersson K-E, Wein AJ (2004) Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56:581\u2013631","journal-title":"Pharmacol Rev"},{"key":"814_CR5","doi-asserted-by":"crossref","unstructured":"Athanasopoulos A, Giannitsas K (2011) An overview of the clinical use of antimuscarinics in the treatment of overactive bladder. Adv Urol:816342","DOI":"10.1155\/2011\/820816"},{"key":"814_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1569-9056(10)60758-0","volume":"9","author":"C Chapple","year":"2010","unstructured":"Chapple C, Wyndaele JJ, Van Kerrebroeck P, Radziszewski P, Dvorak V, Boerrigteret P (2010) Dose-ranging study of once-daily mirabegron (YM-178) a novel selective \u03b23-adrenoceptor agonist in patients with overactive bladder (OAB). Eur Urol Suppl 9:249","journal-title":"Eur Urol Suppl"},{"key":"814_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bjp.0704043","volume":"133","author":"RK Conley","year":"2001","unstructured":"Conley RK, Williams TJ, Ford AP, Rumage AG (2001) The role of \u03b11-adrenoceptors and 5-HT1A receptors in the control of the micturition reflex in male anaesthetized rats. Br J Pharmacol 133:61\u201372","journal-title":"Br J Pharmacol"},{"key":"814_CR8","doi-asserted-by":"crossref","unstructured":"Gillespie JI, Palea S, Guilloteau V, Guerard M, Luel O, Kostajie C (2012) Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the \u03b23-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. BJU Int 110 (2 Pt B):E132-142","DOI":"10.1111\/j.1464-410X.2012.11240.x"},{"key":"814_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1043-6618(91)90090-K","volume":"24","author":"L Guarneri","year":"1991","unstructured":"Guarneri L, Ibba M, Angelico P, Testa R (1991) Effects of oxybutynin, terodiline, and nifedipine on the cystometrogram in conscious rats with infravesical outflow obstruction. Pharmacol Res 24:263\u2013272","journal-title":"Pharmacol Res"},{"key":"814_CR10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.bjp.0701048","volume":"120","author":"SS Hegde","year":"1997","unstructured":"Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, Loury D, Eglen RM (1997) Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 120:1409\u20131418","journal-title":"Br J Pharmacol"},{"key":"814_CR11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(99)00493-8","volume":"55","author":"Y Igawa","year":"2000","unstructured":"Igawa Y (2000) Discussion: functional role of M1, M2, and M3 muscarinic receptors in overactive bladder. Urology 55:47\u201349","journal-title":"Urology"},{"key":"814_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-5347(17)34925-X","volume":"151","author":"Y Igawa","year":"1994","unstructured":"Igawa Y, Mattiasson A, Andersson K-E (1994) Micturition and premicturition contraction in unanesthetized rats with bladder outlet obstruction. J Urol 151:244\u2013249","journal-title":"J Urol"},{"key":"814_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1464-410X.2007.07307.x","volume":"101","author":"Y Kaiho","year":"2007","unstructured":"Kaiho Y, Nishiguchi J, Kwon DD, Chancellor MB, Aroai Y, Snyder PB, Yoshimura N (2007) The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. BJU Int 101:615\u2013620","journal-title":"BJU Int"},{"key":"814_CR14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/nau.21102","volume":"30","author":"A Kanai","year":"2011","unstructured":"Kanai A, Wyndaele JJ, Andersson K-E, Fry C, Ikeda Y, Zabbarova I, Wachter SD (2011) Researching bladder afferents-determining the effects of receptor agonists and botulinum toxin type-A. Neurourol Urodyn 30:684\u2013691","journal-title":"Neurourol Urodyn"},{"key":"814_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1569-9056(11)60870-1","volume":"10","author":"V Khullar","year":"2011","unstructured":"Khullar V, Cambronero J, Str\u00f6berg P, Angulo J, Boerrigter P, Blauwet MB, Wooning M (2011) The efficacy and tolerability of mirabegron in patients with overactive bladder\u2014results from a European-Australian Phase III trial. Eur Urol Suppl 10:278\u2013279","journal-title":"Eur Urol Suppl"},{"key":"814_CR16","unstructured":"Kokubun S, Aikawa K, Shishido K, Ishibashi K, Yanagida T, Nomiya M, Takahashi N, Shiomi H, Ogawa S, Kawashima Y, Yamaguchi O, Hayashi Y (2010) Protection of neurons from denervation prevents bladder dysfunction following bladder outlet obstruction in rat. ICSoffice.org. Available on: http:\/\/www.icsoffice.org\/Abstracts\/Publish\/105\/000498.pdf . Accessed 9 December 2011"},{"key":"814_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0703309","volume":"130","author":"A Lecci","year":"2000","unstructured":"Lecci A, Birder LA, Meini S, Catalioto RM, Tramontana M, Giuliani S, Criscuoli M, Maggi CA (2000) Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats. Br J Pharmacol 130:331\u2013338","journal-title":"Br J Pharmacol"},{"key":"814_CR18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00345-009-0416-y","volume":"27","author":"MC Michel","year":"2009","unstructured":"Michel MC, Sand C (2009) Effect of pre-contraction on \u03b2-adrenoceptor-mediated relaxation of rat urinary bladder. World J Urol 27:711\u2013715","journal-title":"World J Urol"},{"issue":"Suppl 2","key":"814_CR19","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","volume":"147","author":"MC Michel","year":"2006","unstructured":"Michel MC, Vrydag W (2006) \u03b11-, \u03b12- and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147(Suppl 2):S88\u2013S119","journal-title":"Br J Pharmacol"},{"key":"814_CR20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1464-410X.1990.tb14992.x","volume":"66","author":"KH Moore","year":"1990","unstructured":"Moore KH, Hay DM, Imrie AE, Watson A, Goldstein M (1990) Oxybutynin hydrochloride (3\u00a0mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 66:479\u2013485","journal-title":"Br J Urol"},{"key":"814_CR21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0022-5347(05)64531-4","volume":"168","author":"CK Moore","year":"2002","unstructured":"Moore CK, Levendusky M, Longhurst PA (2002) Relationship of mass of obstructed rat bladders and responsiveness to adrenergic stimulation. J Urol 168:1621\u20131625","journal-title":"J Urol"},{"key":"814_CR22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1569-9056(11)60869-5","volume":"10","author":"V Nitti","year":"2011","unstructured":"Nitti V, Herschorn S, Auerbach S, Ayers M, Lee M, Martinet N (2011) The efficacy and safety of mirabegron in patients with overactive bladder syndrome\u2014results from a North-American Phase III trial. Eur Urol Suppl 10:278","journal-title":"Eur Urol Suppl"},{"key":"814_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bjp.0705399","volume":"140","author":"K Read","year":"2003","unstructured":"Read K, Sanger GJ, Ramage AG (2003) Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female rats. Br J Pharmacol 140:53\u201360","journal-title":"Br J Pharmacol"},{"key":"814_CR24","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0022-5347(01)63305-6","volume":"159","author":"H Seguchi","year":"1989","unstructured":"Seguchi H, Nishimura J, Zhou Y, Niiro N, Kumazawa J, Kanaide H (1989) Expression of \u03b23-adrenoceptors in rat detrusor smooth muscle. J Urol 159:2197\u20132201","journal-title":"J Urol"},{"issue":"109","key":"814_CR25","first-page":"4","volume":"97","author":"T Streng","year":"2006","unstructured":"Streng T, Hedlund P, Talo A, Andersson K-E, Gillespie JI (2006) Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat. BJU Int 97(109):4\u20131101","journal-title":"BJU Int"},{"key":"814_CR26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","volume":"321","author":"T Takasu","year":"2007","unstructured":"Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T, Sasamata M, Miyata K, Uchida H, Yamaguchi O (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4-{2-[(2-hydroxy- 2- phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321:642\u2013647","journal-title":"J Pharmacol Exp Ther"},{"key":"814_CR27","first-page":"939","volume":"293","author":"H Takeda","year":"2000","unstructured":"Takeda H, Yamazaki Y, Akahane M, Igawa Y, Ajisawa Y, Nishizawa O (2000) Role of the \u03b23-adrenoceptor in urine storage in the rat: comparison between the selective \u03b23-adrenoceptor agonist, CL316,243, and various smooth muscle relaxants. J Pharmacol Exp Ther 293:939\u201345","journal-title":"J Pharmacol Exp Ther"},{"key":"814_CR28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","volume":"145","author":"JW Thuroff","year":"1991","unstructured":"Thuroff JW, Bunke B, Ebner A, Faber P, de Greeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schafer W, Schwenzer T, Stockle M (1991) Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol 145:813\u2013817","journal-title":"J Urol"},{"key":"814_CR29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-5347(05)65936-8","volume":"166","author":"M Woods","year":"2001","unstructured":"Woods M, Carson N, Norton NW, Sheldon JH, Argentieri TM (2001) Efficacy of the \u03b23-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166:1142\u20131147","journal-title":"J Urol"},{"key":"814_CR30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bjp.0701870","volume":"124","author":"Y Yamazaki","year":"1998","unstructured":"Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, Ajisawa Y (1998) Species differences in the distribution of \u03b2-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124:593\u2013599","journal-title":"Br J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0814-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-012-0814-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-012-0814-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T16:23:27Z","timestamp":1562689407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-012-0814-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1007\/s00210-012-0814-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,9]]}}}